SalehAAlqahtaniMD
Gastroenterology • Baltimore, MDGastrointestinal Cancer, Hepatology & Liver Transplantation, Nutrition, Bariatric Medicine
Professor of Medicine, King Faisal Specialist Hospital & Research Center, Associate Professor of Medicine, Johns Hopkins University
Dr. Alqahtani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
1830 Bldg RM 420
Baltimore, MD 21287Phone+1 410-955-3779
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2007 - 2008
King Abdulaziz University College of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2024 - 2026
FL State Medical License 2023 - 2026
MD State Medical License 2012 - 2026
OH State Medical License 2020 - 2026
NY State Medical License 2020 - 2025
DC State Medical License 2014 - 2024
VA State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- National Board of Physicians and Surgeons Gastroenterology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Transplant Hepatology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059) Start of enrollment: 2014 May 09
- Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis Start of enrollment: 2014 Sep 18
- A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) Start of enrollment: 2014 Oct 28
Publications & Presentations
PubMed
- 60 citationsPoor Awareness of Liver Disease Among Adults With NAFLD in the United States.Saleh A. Alqahtani, James Paik, Rakesh Biswas, Tamoore Arshad, Linda Henry
Hepatology Communications. 2021-07-01 - 60 citationsPrevalence and predictors of anxiety among healthcare workers in Saudi Arabia during the COVID-19 pandemic.Thamer H. Alenazi, Nasser F BinDhim, Meteb H. Alenazi, Hani Tamim, Reem S. Almagrabi
Journal of Infection and Public Health. 2020-11-01 - 125 citationsObesity in Saudi Arabia in 2020: Prevalence, Distribution, and Its Current Association with Various Health ConditionsNora A Althumiri, Mada H Basyouni, Norah AlMousa, Mohammed F. AlJuwaysim, Rasha A. Almubark
Healthcare. 2021-03-11
Press Mentions
Hepatitis C Combo Pill May Cure Those Who Can Afford ItNovember 15th, 2017
5 Ways to Be Kind to Your LiverNovember 24th, 2017
Professional Memberships
- Member
- Member
Other Languages
- Arabic
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/saleh-alqahtani
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
